Caelyx (liposomal DOXOrubicin) 20 Regimen (CP-0161) April 2021
|
|
Caelyx (liposomal DOXOrubicin) 30 CISplatin 50 Regimen (CP-0171) January 2022
|
|
Caelyx (liposomal DOXOrubicin) 40 Regimen (CP-0077) May 2021
|
|
CARBOplatin AUC 2 PACLitaxel 60 (MITO-7) Regimen (CP-0172) September 2021
|
|
CARBOplatin AUC 5 Abraxane (nab-PACLitaxel) 260 Regimen (CP-0196) May 2022
|
|
CARBOplatin AUC 5 Caelyx 30 Regimen (CP-0078) August 2021
|
|
CARBOplatin AUC 5 Caelyx 30 Zirabev (bevacizumab) 10 mg/kg Regimen (CP-0426) November 2023
|
|
CARBOplatin AUC 5 DOCEtaxel 75 Regimen (CP-0080) August 2021
|
|
CARBOplatin AUC 5 gemcitabine 800 D1 & 8 Q21D Regimen (CP-0173) January 2022
|
|
CARBOplatin AUC 5 PACLitaxel 175 Kanjinti(trastuzumab) 6 mg/kg Regimen Cycles 2 to 6 (CP-0194) May 2022
|
|
CARBOplatin AUC 5 PACLitaxel 175 Kanjinti(trastuzumab) 6 mg/kg Regimen Cycles 7+ (CP-0195) May 2022
|
|
CARBOplatin AUC 5 PACLitaxel 175 Kanjinti(trastuzumab) 8 mg/kg Regimen Cycle 1 (CP-0193) May 2022
|
|
CARBOplatin AUC 5 PACLitaxel 175 Regimen (CP-0082) May 2021
|
|
CARBOplatin AUC 5 PACLitaxel 80 Regimen (CP-0079) May 2021
|
|
CARBOplatin AUC 5 Regimen (CP-0083) March 2023
|
|
CARBOplatin AUC 6 Regimen (CP-0084) July 2021
|
|
CISplatin 50 PACLitaxel 175 Regimen (CP-0180) April 2022
|
|
CISplatin 70 gemcitabine 1000 Regimen (CP-0295) March 2023
|
|
CISplatin 75 PACLitaxel 175 Kanjinti(trastuzumab) 6 mg/kg Regimen Cycles 2 to 6 (CP-0198) May 2022
|
|
CISplatin 75 PACLitaxel 175 Kanjinti(trastuzumab) 6 mg/kg Regimen Cycles 7+ (CP-0199) May 2022
|
|
CISplatin 75 PACLitaxel 175 Kanjinti(trastuzumab) 8 mg/kg Regimen Cycle 1 (CP-0197) May 2022
|
|
CISplatin 75 PACLitaxel 175 Regimen (CP-0166) January 2022
|
|
CISplatin 75 Regimen (CP-0167) October 2021
|
|
cyclophosphamide 50 mg PO Regimen (CP-0260) November 2022
|
|
DOCEtaxel 75 Regimen (CP-0168) August 2021
|
|
dostarlimab 1000 mg maintenance Regimen (CP-0430) November 2023
|
|
dostarlimab 500 mg PAClitaxel 175 CARBOplatin AUC 5 Regimen (CP-0429) November 2023
|
|
dostarlimab Regimen (CP-0184) May 2022
|
|
methotrexate 1 mg/kg Regimen (CP-0457) February 2024
|
|
pembrolizumab 2 mg/kg Endometrial Regimen (CP-0332) May 2023
|
|
pembrolizumab 2 mg/kg PACLitaxel 175 CARBOplatin AUC 5 Zirabev (bevacizumab) 15 mg/kg Regimen Cycles 7 + (CP-0347) June 2023
|
|
pembrolizumab 2 mg/kg PACLitaxel 175 CARBOplatin AUC5 Zirabev (bevacizumab) 15 mg/kg Regimen Cycles 1-6 (CP-0346) June 2023
|
|
pembrolizumab 2 mg/kg PACLitaxel 175 CISplatin 50 Zirabev (bevacizumab) 15 mg/kg Regimen Cycles 1 to 6 (CP-0348) June 2023
|
|
pembrolizumab 2 mg/kg PACLitaxel 175 CISplatin 50 Zirabev (bevacizumab) 15 mg/kg Regimen Cycles 1 to 6 (CP-0348) June 2023
|
|
pembrolizumab 2 mg/kg PACLitaxel 175 CISplatin 50 Zirabev (bevacizumab) 15 mg/kg Regimen Cycles 7 + (CP-0349) June 2023
|
|
pembrolizumab 4 mg/kg Endometrial Regimen (CP-0359) May 2023
|
|
pembrolizumab 4 mg/kg lenvatinib 20 mg Regimen (CP-0366) November 2023
|
|
Zirabev (bevacizumab) 15 mg/kg Regimen (CP-0163) July 2022
|
|
Zirabev (bevacizumab) 7.5 mg/kg Regimen (CP-0162) July 2022
|
